Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders.

J Clin Psychiatry 2008 ;69 Suppl 4:15-20

Department of Psychiatry, Indiana University School of Medicine, Christian Sarkine Autism Treatment Center, James Whitcomb Riley Hospital for Children, Indianapolis, IN 46202-4800, USA.

Atypical antipsychotics are emerging as the first-line pharmacologic treatment for irritability (i.e., aggression, self-injurious behavior, and severe tantrums) in children and adolescents with autistic and other pervasive developmental disorders. Results from placebo-controlled and open-label studies of clozapine, risperidone, olanzapine, quetiapine, ziprasidone, and aripiprazole in this subject population are reviewed. Additional placebo-controlled trials and studies of longer-term safety and tolerability are needed.

Download full-text PDF

Source
July 2008
1 Read

Publication Analysis

Top Keywords

pervasive developmental
8
children adolescents
8
autistic pervasive
8
developmental disorders
8
atypical antipsychotics
8
adolescents autistic
8
risperidone olanzapine
4
aggression self-injurious
4
irritability aggression
4
ziprasidone aripiprazole
4
treatment irritability
4
quetiapine ziprasidone
4
self-injurious behavior
4
olanzapine quetiapine
4
behavior severe
4
open-label studies
4
disorders placebo-controlled
4
tantrums children
4
severe tantrums
4
pharmacologic treatment
4

Similar Publications